BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25989631)

  • 41. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures.
    Bergón E; Miravalles E
    Clin Chem Lab Med; 2008; 46(8):1156-62. PubMed ID: 18605957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection and characterization of "difficult" monoclonal components in serum. Gel-based immunofixation techniques or capillary electrophoresis].
    Meunier JC
    Ann Biol Clin (Paris); 1999; 57(5):605-10. PubMed ID: 10518064
    [No Abstract]   [Full Text] [Related]  

  • 43. Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma.
    Claveau JS; Savary Bélanger S; Ahmad I; Delisle JS; De Guire V; Roy J; LeBlanc R
    Blood Cancer J; 2022 Jan; 12(1):3. PubMed ID: 34987163
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guidelines for the analysis of Bence Jones protein.
    Graziani M; Merlini G; Petrini C; ;
    Clin Chem Lab Med; 2003 Mar; 41(3):338-46. PubMed ID: 12705344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interest and limit of a free light chain immunoassay in serum and urine for the diagnosis and the follow-up of monoclonal dysglobulinemia].
    Lopez J; Dauwalder O; Joly P; Dimet I; Bienvenu J; Bernon H
    Ann Biol Clin (Paris); 2006; 64(3):287-97. PubMed ID: 16698567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Challenges of measuring monoclonal proteins in serum.
    Keren DF; Schroeder L
    Clin Chem Lab Med; 2016 Jun; 54(6):947-61. PubMed ID: 26910744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Free light chains and heavy/light chains in monitoring POEMS patients.
    Altinier S; Proko K; Zaninotto M; Ciubotaru D; Seguso M; Varagnolo M; Lessi F; Briani C; Adami F; Plebani M
    Clin Chem Lab Med; 2016 Jun; 54(6):1065-71. PubMed ID: 27071150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
    Bidet A; Marit G; Bérard AM
    Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnostic accuracy of serum protein electrophoresis and free light chain measurements for monoclonal gammopathies].
    Peña C; Ortiz M; Voisin J; Peralta A; Balboa V; Delgado F
    Rev Med Chil; 2018 Jan; 146(1):64-67. PubMed ID: 29806679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies of Bence Jones proteins by immunonephelometry.
    Levinson SS
    Ann Clin Lab Sci; 1992; 22(2):100-9. PubMed ID: 1562164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paraproteinaemia.
    Frank LA; Rabin N
    Br J Hosp Med (Lond); 2015 Jun; 76(6):C82-5. PubMed ID: 26053916
    [No Abstract]   [Full Text] [Related]  

  • 54. Concentrating non-dilute urine before protein electrophoresis for the detection of monoclonal free light chains is unnecessary and wasteful.
    Haran H; Choy KW; Wijeratne N; Tudball R; Doery J; Grigoriadis G; Lu Z
    Pathology; 2018 Aug; 50(5):587-588. PubMed ID: 29970254
    [No Abstract]   [Full Text] [Related]  

  • 55. [5th International Symposium on clinical applications of serum free light chain analysis].
    Decaux O
    Rev Med Interne; 2009 Jan; 30(1):96-100. PubMed ID: 19054596
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
    Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
    Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
    Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
    Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
    Pretorius CJ
    Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods].
    Schneider N; Wynckel A; Kolb B; Sablon E; Gillery P; Maquart FX
    Ann Biol Clin (Paris); 2013; 71(1):13-9. PubMed ID: 23396425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.